Knowledge

What Does The 2026 EPA EtO Regulation Review Mean For Commercial Sterilization Equipment?

 

 

What Changed in the 2026 EPA EtO Proposal?

In March 2026, the U.S. Environmental Protection Agency (EPA) proposed reconsidering parts of the 2024 National Emission Standards for Hazardous Air Pollutants (NESHAP) applicable to commercial facilities using ethylene oxide (EtO) for sterilization. The proposal addresses several requirements introduced in the 2024 rule, including certain risk-based standards, continuous emissions monitoring requirements, aeration room vent provisions, and permanent total enclosure requirements.

This is an important development for the commercial EtO sterilization industry because regulatory requirements influence how sterilization facilities design, upgrade, operate, and monitor their equipment.

However, the 2026 action is a proposed reconsideration, not a blanket removal of EtO emission controls. EPA continues to regulate EtO as a hazardous air pollutant and is evaluating how the applicable standards should be structured under the Clean Air Act.

For equipment manufacturers and medical device producers, the practical question is therefore not simply whether regulations become stricter or less strict. The more important question is:

How should an EtO sterilization system be designed to maintain effective sterilization, controlled gas handling, process monitoring, and regulatory adaptability?

Why Is EtO Sterilization Still Important?

Ethylene oxide remains an important low-temperature sterilization technology because many medical devices cannot tolerate the temperatures or moisture associated with some conventional sterilization methods.

According to the EPA, commercial sterilizers using EtO sterilize approximately 50% of medical devices in the United States, representing around 20 billion devices annually. Applications include syringes, catheters, surgical kits, heart valves, pacemakers, ventilators, gowns, and other medical products.

The technology is particularly relevant when products contain:

Heat-sensitive polymers

Moisture-sensitive components

Complex internal structures

Narrow channels or lumens

Plastic packaging

Multi-component assemblies

For example, PVC medical devices, plastic-packed syringes, catheters, surgical components, and other complex medical devices may require a sterilization process that can penetrate packaging and product structures while operating at relatively low temperatures.

This is why the regulatory discussion is closely connected with the medical device supply chain. If commercial sterilization capacity becomes constrained, medical device manufacturers may face additional production and logistics risks.

At the same time, the industry must address EtO handling, exposure control, residuals, and process validation. The objective of modern equipment is therefore not simply to introduce EO gas into a chamber. It is to create a controlled and repeatable sterilization process.

How Could the Regulatory Review Affect Sterilization Equipment?

The 2026 EPA proposal could influence equipment investment in several ways.

First, commercial sterilization facilities may have greater flexibility in how they demonstrate compliance if the proposed changes are finalized. EPA has proposed changes involving continuous emissions monitoring, new aeration room vent requirements, and permanent total enclosure provisions.

Second, the regulatory discussion reinforces the importance of EtO containment and process control.

A commercial EtO sterilizer normally needs to coordinate multiple stages rather than operate as a single heating or gas-injection machine:

Preconditioning → Vacuum → Humidification → EO Injection → Exposure/Hold → Evacuation → Air Washing → Aeration

Each stage affects the final sterilization result.

For example, relative humidity can influence EO effectiveness, while vacuum and pressure control affect gas distribution. EO concentration and exposure time must be established according to the validated process and product load. After exposure, evacuation and aeration become important parts of the overall process.

Therefore, changing regulatory requirements do not eliminate the need for engineering control. Instead, they increase the importance of selecting an EtO sterilization system with appropriate process monitoring and safety architecture.

What Should Modern EtO Sterilizers Control?

For medical device manufacturers, purchasing an EO sterilizer machine should not be based only on chamber volume.

A complete system may need to control and record multiple process parameters, depending on the application and validation strategy.

Temperature Control

The chamber temperature needs to remain within the validated process range. Stable temperature distribution helps maintain consistent sterilization conditions across the load.

Relative Humidity Control

Humidity is an important parameter in EtO sterilization. A properly designed humidification system can help establish repeatable conditions before EO exposure.

Vacuum and Pressure Control

Vacuum stages help prepare the chamber and support controlled gas introduction and removal. Pressure monitoring can also provide information about chamber conditions during the cycle.

EO Injection

A controlled EO injection system allows the sterilization recipe to define the required gas introduction conditions rather than relying on uncontrolled manual operation.

Exposure and Hold Time

The exposure stage must follow the validated sterilization cycle. Time, temperature, humidity, EO concentration, load configuration, packaging, and product characteristics should be considered together.

Aeration

Aeration provides controlled air exchange after sterilization. It is particularly important for products that can absorb or retain EO.

The latest ISO 10993-7:2026 specifies allowable limits for residual EO and ethylene chlorohydrin (ECH) in applicable EO-sterilized medical devices, as well as measurement and conformity procedures.

This makes aeration and residual management an important consideration when designing an EtO sterilization system for medical devices.

Safety Interlocks and Monitoring

A commercial system may also incorporate:

Chamber pressure monitoring

Temperature monitoring

EO concentration monitoring

Leak detection

Door interlocks

Emergency shutdown

Exhaust control

Alarm management

Cycle data recording

The exact configuration should be determined according to the customer's process, facility, load, applicable regulations, and validation requirements.

Riches Custom EtO Sterilization System Solutions

At Hangzhou Riches Engineering, we approach EtO sterilization equipment as an engineering system rather than a standard chamber with fixed parameters.

Our custom EtO sterilization systems can be configured according to the customer's product type, chamber volume, production capacity, facility conditions, sterilization process, and automation requirements.

3D Design Before Manufacturing

Before equipment manufacturing, Riches can develop a 3D design of the EtO sterilization system according to the customer's available installation area, chamber dimensions, access requirements, ventilation arrangement, and supporting utilities.

This allows engineering teams to review the equipment layout before fabrication.

Customized Chamber Configuration

Different medical devices require different loading methods and chamber capacities.

For example, a system designed for plastic-packed syringes may have different loading and circulation requirements from a system used for long catheter assemblies.

Riches can configure chamber dimensions, loading arrangements, door configuration, internal circulation, and process connections according to the intended application.

Integrated Process Control

Our EtO sterilization equipment can integrate control of:

Vacuum + Temperature + Relative Humidity + EO Injection + Exposure Time + Exhaust + Aeration

The objective is to provide a repeatable process sequence that can be adjusted according to the customer's validated sterilization recipe.

Safety System Integration

Because EO is a hazardous and flammable gas, equipment design requires appropriate safety measures.

Depending on the project, Riches can integrate gas detection, pressure monitoring, safety interlocks, emergency shutdown functions, exhaust control, and alarm systems into the equipment architecture.

Installation, Commissioning and Validation Support

Riches' project scope can extend beyond equipment manufacturing.

We can support customers through:

Equipment Design → Manufacturing → Factory Testing → Installation → Commissioning → IQ/OQ/PQ Support

This approach helps customers connect the physical equipment with their production process and validation requirements.

EtO Sterilizer Applications for Medical Device Production

The flexibility of EtO sterilization makes it suitable for a range of medical device applications.

EO Sterilizer for Syringe Production

For plastic-packed syringes, the sterilization system needs to consider product packaging, load configuration, chamber circulation, humidity, EO exposure, evacuation, and aeration.

EtO Sterilizer for Catheters

Catheters may contain narrow channels and polymeric materials that require careful process development. The sterilization cycle should therefore be established according to product geometry, packaging, material compatibility, and validated penetration requirements.

Low-Temperature EtO Sterilization for PVC Devices

PVC and other temperature-sensitive polymers can be suitable candidates for low-temperature EtO sterilization when the process is properly developed and validated.

EO Gas Chamber for Complex Medical Devices

For complex assemblies, chamber volume and loading configuration become important engineering variables. Riches can customize the EO gas chamber according to the customer's production capacity and product loading method.

What Should Buyers Consider When Selecting an EtO Sterilizer?

The 2026 regulatory discussion provides an important reminder: buying an EtO sterilizer is not simply a question of selecting the largest chamber.

Before requesting a quotation, medical device manufacturers should define several parameters.

Product

What product will be sterilized?

Syringes, catheters, PVC devices, surgical kits, packaged components, or other medical devices may require different process configurations.

Chamber Volume

The required chamber size should correspond to the product dimensions, loading method, batch quantity, and expected production capacity.

Packaging

Packaging materials can influence gas penetration, EO absorption, aeration, and residual levels.

Process Parameters

The project should define the required operating range for:

Temperature / Relative Humidity / Vacuum / EO Concentration / Exposure Time / Aeration

Facility Conditions

Available floor space, ceiling height, ventilation, utilities, exhaust arrangement, loading access, and operator workflow can all influence equipment design.

Automation

Customers should also determine whether they require recipe management, automated cycle control, alarm recording, data logging, remote monitoring, or integration with existing production systems.

A detailed technical specification at the beginning of the project allows the EtO sterilizer manufacturer to design the chamber, control system, auxiliary equipment, and safety functions around the actual production process.

Conclusion

The 2026 EPA Reconsideration Of Commercial EtO Sterilization Standards Highlights A Broader Issue For The Industry: EtO Sterilization Remains Closely Connected To Both Medical Device Supply-Chain Security And Environmental Control Requirements.

EPA's Proposal Addresses Specific Provisions Of The 2024 NESHAP Rule, But It Does Not Mean That EtO Safety And Emission Management Are No Longer Relevant. The Regulatory Framework Is Still Subject To Rulemaking, While Manufacturers Must Continue To Consider Applicable Requirements For Their Facilities And Markets.

For Medical Device Manufacturers, This Makes Equipment Selection Increasingly Important.

A Modern EtO Sterilization System Should Provide More Than A Sealed Chamber. It Should Integrate Controlled EO Injection, Vacuum Management, Humidity Control, Temperature Control, Exhaust And Aeration Processes, Safety Interlocks, Process Monitoring, And Configurable Automation According To The Application.

At Riches, We Provide Custom EtO Sterilization Systems For Medical Device Manufacturers, With Engineering Support Covering 3D Equipment Design, Chamber Configuration, Process Control, Manufacturing, Installation, Commissioning, And IQ/OQ/PQ Support.

If You Are Planning A New EtO Sterilizer, Expanding An Existing Sterilization Line, Or Developing A Customized EO Sterilization Process, Providing Your Product Type, Chamber/Load Requirements, Target Production Capacity, Packaging Configuration, Available Installation Space, And Required Automation Level Allows Our Engineering Team To Develop A More Suitable System Configuration.

Riches - Custom EtO Sterilization Systems Designed Around Your Medical Device Process.

 

 

 

You Might Also Like

Send Inquiry